| Oloxen (n = 42) | Xen (n = 30) | p-value |
---|---|---|---|
Age, years (mean ± SD) | 59.81 ± 15.62 | 58.10 ± 15.93 | 0.651* |
Gender, n, male:female (%) | 26:16 (61.9%:38.1%) | 19:11(63.3%:36.7%) | 0.902†|
Laterality, n, OD:OS (%) | 17:25 (40.5%:59.5%) | 16:14 (53.3%:46.7%) | 0.280†|
HTN, n, yes:no (%) | 14:28 (33.3%:66.7%) | 11:19 (36.7%:63.3%) | 0.770†|
DM, n, yes:no (%) | 10:32 (23.8%:76.2%) | 5:25 (16.7%:83.3%) | 0.462†|
Preoperative visual acuity, logMAR (mean ± SD) | 0.34 ± 0.43 | 0.56 ± 0.51 | 0.059* |
Preoperative intraocular pressure, mmHg (mean ± SD) | 17.60 ± 5.87 | 20.47 ± 6.46 | 0.054* |
Prior glaucoma surgery, n, yes:no (%) | 5:37 (11.9%:88.1%) | 4:26(13.3%:86.7%) | 0.858†|
Number of preoperative anti-glaucoma medications, n (mean ± SD) | 3.57 ± 0.83 | 3.67 ± 1.32 | 0.709* |
Preoperative diagnosis (%) |  |  | 0.770†|
Primary open-angle glaucoma | 28 (66.7%) | 19 (63.3%) | Â |
Secondary open-angle glaucoma | 14 (33.3%) | 11 (36.7%) | Â |
Lens, n, phakic:pseudophakic (%) | 20:22 (47.6%:52.4%) | 12:18 (40.0%:60.0%) | 0.532†|
CCT, (mean ± SD) | 531.42 ± 46.76 | 535.27 ± 37.99 | 0.786* |
ECD, (mean ± SD) | 2340.36 ± 481.67 | 2233.23 ± 584.71 | 0.398* |
Axial length, mm, (mean ± SD) | 25.05 ± 2.19 | 25.91 ± 2.41 | 0.162* |
RNFL thickness, (mean ± SD) | 66.50 ± 9.86 | 71.56 ± 10.67 | 0.068* |
VFI, (mean ± SD) | 55.73 ± 25.11 | 58.89 ± 30.40 | 0.654* |
MD, (mean ± SD) | -15.73 ± 7.90 | -14.57 ± 9.15 | 0.590* |
PSD, (mean ± SD) | 9.93 ± 3.45 | 8.35 ± 4.75 | 0.154* |